Technology Highlights

Sequential Measurement Based Multi-Parameter Microfluidic Flow Cytomolecular Analyser

Key Highlights

This project integrates microfluidic chip technology with flow cytometry and our proprietary MSTS Transfer™ Technology to create a groundbreaking single-laser, 96+ parameter microfluidic flow cytomolecular analyser. Utilising one laser, it efficiently performs multi-parameter measurements, surpassing traditional flow cytometers  while incorporating the essential functions of immune analysers.

Challenges

• IBS-D affects 10–20% of the global population and significantly reduces the quality of life
• Conventional Western treatments focus on transient symptom control, often resulting in limited efficacy and high recurrence
• Long-term pharmacological management is associated with side effects and poor patient compliance 

Breakthrough Technology

• Optimised from a classical Chinese medicine prescription using evidence-based pharmacological and clinical research
• Multi-target, multi-pathway mechanism regulating intestinal motility and inflammation, while alleviating visceral hypersensitivity via a novel butyrate-producing pathway
• Proven symptom improvement after 8 weeks of treatment with sustained effects remaining even after discontinuation
• Patented formulation with regulatory approval for clinical trials in both Hong Kong and the Chinese Mainland

Industry Applications

• Gastrointestinal therapeutics
• Preventive and integrative medicine
• Chinese medicine based drug development
• Hospital, outpatient and primary care IBS management 

Business Benefits

• Large and growing IBS patient market with unmet clinical needs
• Patented formulation with strong IP protection
• Lower recurrence enhances long term patient retention
• Strong commercialisation potential via licensing to pharmaceutical companies